CytoDyn Inc. Annual Operating Income (Loss) in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
CytoDyn Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2023.
  • CytoDyn Inc. Operating Income (Loss) for the quarter ending February 28, 2025 was -$4M, a 17.3% decline year-over-year.
  • CytoDyn Inc. Operating Income (Loss) for the twelve months ending February 28, 2025 was $8.09M.
  • CytoDyn Inc. annual Operating Income (Loss) for 2023 was -$18.1M, a 55.5% increase from 2022.
  • CytoDyn Inc. annual Operating Income (Loss) for 2022 was -$40.6M, a 72.1% increase from 2021.
  • CytoDyn Inc. annual Operating Income (Loss) for 2021 was -$145M, a 39% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$18.1M +$22.5M +55.5% Jun 1, 2023 May 31, 2024 10-K 2024-08-15
2022 -$40.6M +$105M +72.1% Jun 1, 2022 May 31, 2023 10-K 2024-08-15
2021 -$145M -$40.8M -39% Jun 1, 2021 May 31, 2022 10-K 2023-09-14
2020 -$105M -$29.9M -40.1% Jun 1, 2020 May 31, 2021 10-K 2022-08-15
2019 -$74.6M -$18.8M -33.7% Jun 1, 2019 May 31, 2020 10-K 2022-08-15
2018 -$55.9M -$9.93M -21.6% Jun 1, 2018 May 31, 2019 10-K 2021-07-30
2017 -$45.9M -$18.6M -68% Jun 1, 2017 May 31, 2018 10-K 2020-08-14
2016 -$27.3M -$6.16M -29.1% Jun 1, 2016 May 31, 2017 10-K 2019-08-14
2015 -$21.2M -$1.58M -8.06% Jun 1, 2015 May 31, 2016 10-K 2018-07-27
2014 -$19.6M -$11.5M -142% Jun 1, 2014 May 31, 2015 10-K 2016-07-19
2013 -$8.11M -$119K -1.49% Jun 1, 2013 May 31, 2014 10-K 2015-07-10
2012 -$7.99M -$538K -7.21% Jun 1, 2012 May 31, 2013 10-K 2014-07-10
2011 -$7.46M -$3.76M -102% Jun 1, 2011 May 31, 2012 10-K 2013-08-29
2010 -$3.7M Jun 1, 2010 May 31, 2011 10-K 2012-08-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.